The Singapore Liver Cancer Recurrence

• Published in: PloS one Vol. 10; no. 4; p. e0118658
• Main Authors: Ang, Soo Fan, Ng, Elizabeth Shu-Hui, Li, Huihua, Ong, Yu-Han, Choo, Su Pin, Ngeow, Joanne, Toh, Han Chong, Lim, Kiat Hon, Yap, Hao Yun, Tan, Chee Kiat, Ooi, London Lucien Peng Jin, Chung, Alexander Yaw Fui, Chow, Pierce Kah Hoe, Foo, Kian Fong, Tan, Min-Han, Cheow, Peng Chung
• Format: Journal Article
• Language: English
• Published: Public Library of Science 01-04-2015
• Subjects: Cancer patients; Cancer recurrence; Care and treatment; Glycoproteins; Hepatocellular carcinoma; Liver cirrhosis; Prognosis
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0118658

Surgery is the primary curative option in patients with hepatocellular carcinoma (HCC). Current prognostic models for HCC are developed on datasets of primarily patients with advanced cancer, and may be less relevant to resectable HCC. We developed a postoperative nomogram, the Singapore Liver Cancer Recurrence (SLICER) Score, to predict outcomes of HCC patients who have undergone surgical resection. Records for 544 consecutive patients undergoing first-line curative surgery for HCC in one institution from 1992-2007 were reviewed, with 405 local patients selected for analysis. Freedom from relapse (FFR) was the primary outcome measure. An outcome-blinded modeling strategy including clustering, data reduction and transformation was used. We compared the performance of SLICER in estimating FFR with other HCC prognostic models using concordance-indices and likelihood analysis. A nomogram predicting FFR was developed, incorporating non-neoplastic liver cirrhosis, multifocality, preoperative alpha-fetoprotein level, Child-Pugh score, vascular invasion, tumor size, surgical margin and symptoms at presentation. Our nomogram outperformed other HCC prognostic models in predicting FFR by means of log-likelihood ratio statistics with good calibration demonstrated at 3 and 5 years post-resection and a concordance index of 0.69. Using decision curve analysis, SLICER also demonstrated superior net benefit at higher threshold probabilities. The SLICER score enables well-calibrated individualized predictions of relapse following curative HCC resection, and may represent a novel tool for biomarker research and individual counseling.